Related Experiment Video
Updated: Jul 4, 2025
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Progress of studies on natural products for glioblastoma therapy
Fang Xu1,2, Yi-Hui Yang1,2, Hong Yang1,2
1The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.
Abstract:
Glioblastoma (GBM) is the most common, malignant, and lethal primary brain tumor in adults. Up to now, the chemotherapy approaches for GBM are limited. Therefore, more studies on identifying and exploring new chemotherapy drugs or strategies overcome the GBM are essential. Natural products are an important source of drugs against various human diseases including cancers. With the better understanding of the molecular etiology of GBM, the development of new anti-GBM drugs has been increasing. Here, we summarized recent researches of natural products for the GBM therapy and their potential mechanisms in details, which will provide new ideas for the research on natural products and promote developing drugs from nature products for GBM therapy.
Insights
Natural products offer promising avenues for glioblastoma (GBM) therapy due to limited chemotherapy options. This review explores recent research on natural compounds and their mechanisms for treating this aggressive brain cancer.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Research
Background:
- Glioblastoma (GBM) is the most prevalent and lethal primary adult brain tumor.
- Current chemotherapy options for GBM are significantly limited, necessitating novel therapeutic strategies.
- Natural products represent a rich source of potential anti-cancer agents.
Purpose of the Study:
- To review recent research on natural products as potential therapies for glioblastoma.
- To detail the mechanisms of action for these natural products against GBM.
- To provide insights for developing new GBM drugs derived from natural sources.
Main Methods:
- Literature review of recent scientific research.
- Analysis of studies on natural products and their efficacy in glioblastoma models.
- Summary of identified mechanisms of action for anti-GBM natural compounds.
Main Results:
- Numerous natural products have demonstrated anti-glioblastoma activity.
- Various mechanisms, including cytotoxic, anti-proliferative, and anti-angiogenic effects, are associated with these compounds.
- Understanding these mechanisms can guide the development of targeted therapies.
Conclusions:
- Natural products hold significant potential for the development of novel glioblastoma therapies.
- Further research into the mechanisms of natural compounds can lead to improved treatment strategies for GBM.
- Translating natural product research into clinical applications is crucial for advancing GBM treatment.
